Assessment parameter | Scale | |||
---|---|---|---|---|
Clincal reports | Prognostic factors | Age | 0 | 2 |
 |  | Gender | 0 | 2 |
 |  | Performance status | 0 | 2 |
 | Tumor characteristics | Location of primary tumor | 0 | 2 |
 |  | Number of metastatic sites | 0 | 2 |
 |  | Size of hepatic metastasis | 0 | 2 |
 |  | Differentiation grade | 0 | 2 |
 | Description of the results of survival analysis | Number of patients | 0 | 2 |
 |  | Number of deaths | 0 | 2 |
 |  | Follow-up duration | 0 | 2 |
 |  | Number of patients lost to follow-up | 0 | 2 |
 |  | Univariate and multivariate analyses | 0 | 2 |
 |  | Description of statistical tests | 0 | 2 |
 |  | Survival definition | 0 | 2 |
 |  | SUV cutoff definition or response definition | 0 | 2 |
Subscores | Â | Â | Â | Â |
PET/CT reports | Patients’ Characteristics | Weight | 0 | 2 |
 |  | Glycaemia | 0 | 2 |
 | 18FDG PET acquisition protocol characteristics | Injected dose of 18FDG | 0 | 2 |
 |  | Delay between injection | 0 | 2 |
 |  | Data acquisition | 0 | 2 |
 |  | Fasting duration | 0 | 2 |
 | Technical Parameters | SUV formula | 0 | 2 |
 |  | Type of PET/CT engine | 0 | 2 |
 |  | Type of SUV attenuation and reconstruction parameters | 0 | 2 |
Subscores | Â | Â | Â | Â |
Total scores | Â | Â | Â | Â |